- Home
- KPRX vs SNTG Comparison
KPRX vs SNTG Comparison
Compare KPRX & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- SNTG
- Stock Information
- Founded
- KPRX 1998
- SNTG 2009
- Country
- KPRX United States
- SNTG China
- Employees
- KPRX N/A
- SNTG N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SNTG Finance: Consumer Services
- Sector
- KPRX Health Care
- SNTG Finance
- Exchange
- KPRX Nasdaq
- SNTG Nasdaq
- Market Cap
- KPRX 9.2M
- SNTG 8.2M
- IPO Year
- KPRX N/A
- SNTG 2021
- Fundamental
- Price
- KPRX $2.52
- SNTG $2.66
- Analyst Decision
- KPRX Strong Buy
- SNTG
- Analyst Count
- KPRX 1
- SNTG 0
- Target Price
- KPRX $10.00
- SNTG N/A
- AVG Volume (30 Days)
- KPRX 52.9K
- SNTG 86.7K
- Earning Date
- KPRX 11-07-2025
- SNTG 05-14-2025
- Dividend Yield
- KPRX N/A
- SNTG N/A
- EPS Growth
- KPRX N/A
- SNTG N/A
- EPS
- KPRX N/A
- SNTG N/A
- Revenue
- KPRX N/A
- SNTG $107,507.00
- Revenue This Year
- KPRX N/A
- SNTG N/A
- Revenue Next Year
- KPRX N/A
- SNTG N/A
- P/E Ratio
- KPRX N/A
- SNTG N/A
- Revenue Growth
- KPRX N/A
- SNTG N/A
- 52 Week Low
- KPRX $2.21
- SNTG $1.43
- 52 Week High
- KPRX $4.18
- SNTG $12.70
- Technical
- Relative Strength Index (RSI)
- KPRX 42.43
- SNTG 45.11
- Support Level
- KPRX $2.21
- SNTG $2.44
- Resistance Level
- KPRX $2.80
- SNTG $3.20
- Average True Range (ATR)
- KPRX 0.15
- SNTG 0.20
- MACD
- KPRX -0.03
- SNTG -0.07
- Stochastic Oscillator
- KPRX 41.89
- SNTG 25.43
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.